journal article·2020-07

Fabrication and evaluation of Olopatadine hydrochloride ocular inserts

Junaid Qureshi, Furqan Muhammad Iqbal, Farwa Hussain, Hira Ijaz, Muhammad Fakhruddin Aamir, Mehreen Afzal

Publisher page

Abstract

Development of the novel delivery provides optimal drug delivery via facilitated transcorneal penetration and ultimately improved retention time in eye. The present study was to fabricate and evaluate the performance of ocular inserts of Olopatadine hydrochloride by consuming polymers such as hydroxypropyl methylcellulose, gelatin, and chitosan at various concentrations with different plasticizers using solvent casting technique. Prepared formulations were evaluated for thickness, weight variations, drug content, surface pH, swelling studies, and in vitro drug release. Fourier transform infrared spectroscopy studies showed that interaction occurred between polymer and drug, and successful drug entrapment occurred in the matrix. All formulations showed excellent film-forming capacity with good thickness and weight uniformity. Folding endurance proved that the inserts were soft, elastic, and flexible. Chitosan-based ocular inserts showed greater swelling index as compared to gelatin and hydroxypropyl methylcellulose inserts. In vitro studies showed prolonged drug release and followed zero-order kinetic model and non-Fickian drug release.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan

Faculty of Pharmacy, University of Sargodha, Sargodha, Punjab, Pakistan

Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan

Drug Regulatory Authority of Pakistan, Islamabad, Pakistan

Department of Pathology, Nishtar Medical University, Multan, Pakistan

References (31)

Show source-provided references
1. 10.15171/apb.2018.00310.15171/apb.2018.003 ↗
2. Saraf SA, Kanoujia J, Singh S, et al. Ocular drug delivery systems. In: In-vitro and in-vivo tools in drug delivery research for optimum clinical outcome. Boca Raton, FL: CRC Press, 2018, pp.135–172.10.1201/b22448-5 ↗
3. Shanmugam S · Trends Drug Deliv · 2018 · 4 · 20
4. 10.1016/j.jddst.2018.05.01010.1016/j.jddst.2018.05.010 ↗
5. 10.1016/j.jaci.2017.12.54110.1016/j.jaci.2017.12.541 ↗
6. 10.1016/j.jaci.2017.12.22210.1016/j.jaci.2017.12.222 ↗
7. Nakatani H, Gomes P, Bradford R, et al. Alcaftadine 0.25% versus Olopatadine 0.1% in preventing cedar pollen allergic conjunctivitis in Japan: a randomized study. Ocular Immunol Inflamm . Epub ahead of print 15 March 2018. DOI: 10.1080/09273948.2018.1432764.10.1080/09273948.2018.1432764 ↗
8. 10.1007/s10928-018-9588-710.1007/s10928-018-9588-7 ↗
9. 10.3126/kuset.v6i1.331810.3126/kuset.v6i1.3318 ↗
10. 10.1111/j.2042-7158.2012.01587.x10.1111/j.2042-7158.2012.01587.x ↗
11. 10.2478/v10007-007-0037-110.2478/v10007-007-0037-1 ↗
12. Sharma S · Global J Pharmacol · 2015 · 9 · 97
13. Gevariya H · Asian J Pharm · 2014 · 3
14. El Gamal SS · Asian J Pharm Sci · 2008 · 3 · 58
15. Ara T · Int J Scientific Res Publ · 2015 · 5
16. 10.4103/0975-7406.8077310.4103/0975-7406.80773 ↗
17. 10.1016/j.ijpharm.2008.09.04710.1016/j.ijpharm.2008.09.047 ↗
18. 10.1016/j.ijpharm.2014.06.01710.1016/j.ijpharm.2014.06.017 ↗
19. Dave V · Turk J Pharm Sci · 2013 · 10 · 205
20. Sreenivas S · Iran J Pharmacol Therapeut · 2006 · 5 · 159
21. Shoaib M · Pak J Pharm Sci · 2006 · 19 · 119
22. 10.1080/0271368080202310410.1080/02713680802023104 ↗
23. Qureshi J · Latin Am J Pharm · 2014 · 33 · 1533
24. 10.2174/18722111179547143610.2174/187221111795471436 ↗
25. 10.1055/s-0033-134000810.1055/s-0033-1340008 ↗
26. 10.1016/j.xphs.2016.05.03110.1016/j.xphs.2016.05.031 ↗
27. Sultana YA · Acta Pharm · 2005 · 55 · 305
28. 10.1371/journal.pone.013314910.1371/journal.pone.0133149 ↗
29. 10.1016/S0378-5173(02)00421-010.1016/S0378-5173(02)00421-0 ↗
30. 10.1016/j.jddst.2016.01.00810.1016/j.jddst.2016.01.008 ↗
31. 10.1517/17425247.2015.105941910.1517/17425247.2015.1059419 ↗